TD Cowen lowered the firm’s price target on DexCom to $110 from $150 and keeps an Outperform rating on the shares. The firm said they posted impressive 3Q results, with revenue and EPS easily topping Street projections. They also announced a $500M share repurchase program in tandem with the 3Q report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DXCM: